Nightstar Therapeutics Limited

Home » Nightstar Therapeutics Limited

IPO

Nightstar Therapeutics Limited

They are a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness.

Symbol

NITE

Price Range
$13.00 - $15.00

Anticipated Shares
1,000,000

Anticipated Date
TBD

Underwriters
Jefferies, Leerink Partners, BMO Capital Markets

To view the prospectus for Nightstar Therapeutics Limited IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253